Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II
A new class of drug developed by the Swedish biotech company Affibody has proved better…
22/06/2020 - 3 minutes
Affibody
Affibody Signs €208M Deal To Market Autoimmune Drug in China
Swedish biotech Affibody and Chinese firm Inmagene Biopharmaceuticals will work together to develop and commercialize…
15/05/2020 - 3 minutes
How Sweden’s Intellectual Property Law Boosts Biotech Innovation
Founding one biotech company and making a success of it is difficult enough, but Mathias…
05/11/2019 - 10 minutes
